A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease

<p>Abstract</p> <p>Background</p> <p>Triple-negative breast cancer (TNBC) exhibit characteristics quite distinct from other kinds of breast cancer, presenting as an aggressive disease--recurring and metastasizing more often than other kinds of breast cancer, without tum...

Full description

Bibliographic Details
Main Authors: Kau Punit, Nagaraja Ganachari M, Zheng Hongying, Gizachew Dawit, Galukande Moses, Krishnan Sunil, Asea Alexzander
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Cancer
Subjects:
Online Access:http://www.biomedcentral.com/1471-2407/12/120
id doaj-e47bcb68577847589a6a1a8450c16fda
record_format Article
spelling doaj-e47bcb68577847589a6a1a8450c16fda2020-11-25T00:24:17ZengBMCBMC Cancer1471-24072012-03-0112112010.1186/1471-2407-12-120A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human diseaseKau PunitNagaraja Ganachari MZheng HongyingGizachew DawitGalukande MosesKrishnan SunilAsea Alexzander<p>Abstract</p> <p>Background</p> <p>Triple-negative breast cancer (TNBC) exhibit characteristics quite distinct from other kinds of breast cancer, presenting as an aggressive disease--recurring and metastasizing more often than other kinds of breast cancer, without tumor-specific treatment options and accounts for 15% of all types of breast cancer with higher percentages in premenopausal African-American and Hispanic women. The reason for this aggressive phenotype is currently the focus of intensive research. However, progress is hampered by the lack of suitable TNBC cell model systems.</p> <p>Methods</p> <p>To understand the mechanistic basis for the aggressiveness of TNBC, we produced a stable TNBC cell line by sorting for 4T1 cells that do not express the estrogen receptor (ER), progesterone receptor (PgR) or the gene for human epidermal growth factor receptor 2 (HER2). As a control, we produced a stable triple-positive breast cancer (TPBC) cell line by transfecting 4T1 cells with rat HER2, ER and PgR genes and sorted for cells with high expression of ER and PgR by flow cytometry and high expression of the HER2 gene by Western blot analysis.</p> <p>Results</p> <p>We isolated tumor-initiating cells (TICs) by sorting for CD24<sup>+</sup>/CD44<sup>high</sup>/ALDH1<sup>+ </sup>cells from TNBC (TNBC-TICs) and TPBC (TPBC-TICs) stable cell lines. Limiting dilution transplantation experiments revealed that CD24<sup>+</sup>/CD44<sup>high</sup>/ALDH1<sup>+ </sup>cells derived from TNBC (TNBC-TICs) and TPBC (TPBC-TICs) were significantly more effective at repopulating the mammary glands of naïve female BALB/c mice than CD24<sup>-</sup>/CD44<sup>-</sup>/ALDH1<sup>- </sup>cells. Implantation of the TNBC-TICs resulted in significantly larger tumors, which metastasized to the lungs to a significantly greater extent than TNBC, TPBC-TICs, TPBC or parental 4T1 cells. We further demonstrated that the increased aggressiveness of TNBC-TICs correlates with the presence of high levels of mouse twenty-five kDa heat shock protein (Hsp25/mouse HspB1) and seventy-two kDa heat shock protein (Hsp72/HspA1A).</p> <p>Conclusions</p> <p>Taken together, we have developed a TNBC-TICs model system based on the 4T1 cells which is a very useful metastasis model with the advantage of being able to be transplanted into immune competent recipients. Our data demonstrates that the TNBC-TICs model system could be a useful tool for studies on the pathogenesis and therapeutic treatment for TNBC.</p> http://www.biomedcentral.com/1471-2407/12/120Triple-negative breast cancerMouse and human HspB1Hsp25Hsp27Hsp72/HspA1AHeat shockCancer stem cellsTumor-initiating cells
collection DOAJ
language English
format Article
sources DOAJ
author Kau Punit
Nagaraja Ganachari M
Zheng Hongying
Gizachew Dawit
Galukande Moses
Krishnan Sunil
Asea Alexzander
spellingShingle Kau Punit
Nagaraja Ganachari M
Zheng Hongying
Gizachew Dawit
Galukande Moses
Krishnan Sunil
Asea Alexzander
A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
BMC Cancer
Triple-negative breast cancer
Mouse and human HspB1
Hsp25
Hsp27
Hsp72/HspA1A
Heat shock
Cancer stem cells
Tumor-initiating cells
author_facet Kau Punit
Nagaraja Ganachari M
Zheng Hongying
Gizachew Dawit
Galukande Moses
Krishnan Sunil
Asea Alexzander
author_sort Kau Punit
title A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
title_short A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
title_full A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
title_fullStr A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
title_full_unstemmed A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
title_sort mouse model for triple-negative breast cancer tumor-initiating cells (tnbc-tics) exhibits similar aggressive phenotype to the human disease
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2012-03-01
description <p>Abstract</p> <p>Background</p> <p>Triple-negative breast cancer (TNBC) exhibit characteristics quite distinct from other kinds of breast cancer, presenting as an aggressive disease--recurring and metastasizing more often than other kinds of breast cancer, without tumor-specific treatment options and accounts for 15% of all types of breast cancer with higher percentages in premenopausal African-American and Hispanic women. The reason for this aggressive phenotype is currently the focus of intensive research. However, progress is hampered by the lack of suitable TNBC cell model systems.</p> <p>Methods</p> <p>To understand the mechanistic basis for the aggressiveness of TNBC, we produced a stable TNBC cell line by sorting for 4T1 cells that do not express the estrogen receptor (ER), progesterone receptor (PgR) or the gene for human epidermal growth factor receptor 2 (HER2). As a control, we produced a stable triple-positive breast cancer (TPBC) cell line by transfecting 4T1 cells with rat HER2, ER and PgR genes and sorted for cells with high expression of ER and PgR by flow cytometry and high expression of the HER2 gene by Western blot analysis.</p> <p>Results</p> <p>We isolated tumor-initiating cells (TICs) by sorting for CD24<sup>+</sup>/CD44<sup>high</sup>/ALDH1<sup>+ </sup>cells from TNBC (TNBC-TICs) and TPBC (TPBC-TICs) stable cell lines. Limiting dilution transplantation experiments revealed that CD24<sup>+</sup>/CD44<sup>high</sup>/ALDH1<sup>+ </sup>cells derived from TNBC (TNBC-TICs) and TPBC (TPBC-TICs) were significantly more effective at repopulating the mammary glands of naïve female BALB/c mice than CD24<sup>-</sup>/CD44<sup>-</sup>/ALDH1<sup>- </sup>cells. Implantation of the TNBC-TICs resulted in significantly larger tumors, which metastasized to the lungs to a significantly greater extent than TNBC, TPBC-TICs, TPBC or parental 4T1 cells. We further demonstrated that the increased aggressiveness of TNBC-TICs correlates with the presence of high levels of mouse twenty-five kDa heat shock protein (Hsp25/mouse HspB1) and seventy-two kDa heat shock protein (Hsp72/HspA1A).</p> <p>Conclusions</p> <p>Taken together, we have developed a TNBC-TICs model system based on the 4T1 cells which is a very useful metastasis model with the advantage of being able to be transplanted into immune competent recipients. Our data demonstrates that the TNBC-TICs model system could be a useful tool for studies on the pathogenesis and therapeutic treatment for TNBC.</p>
topic Triple-negative breast cancer
Mouse and human HspB1
Hsp25
Hsp27
Hsp72/HspA1A
Heat shock
Cancer stem cells
Tumor-initiating cells
url http://www.biomedcentral.com/1471-2407/12/120
work_keys_str_mv AT kaupunit amousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT nagarajaganacharim amousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT zhenghongying amousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT gizachewdawit amousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT galukandemoses amousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT krishnansunil amousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT aseaalexzander amousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT kaupunit mousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT nagarajaganacharim mousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT zhenghongying mousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT gizachewdawit mousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT galukandemoses mousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT krishnansunil mousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
AT aseaalexzander mousemodelfortriplenegativebreastcancertumorinitiatingcellstnbcticsexhibitssimilaraggressivephenotypetothehumandisease
_version_ 1725352873355640832